Sistem Penghantaran Obat Mutakhir: Tantangan Formulasi Nano untuk Fitokimia yang Sulit Larut dalam Air
Bilah Samping Artikel
Isi Artikel Utama
Page: 1220-1238
Abstrak
Kelarutan air yang rendah dan bioavailabilitas oral yang rendah dari berbagai senyawa fitokimia (Kelas BCS II dan IV) masih menjadi hambatan utama dalam pengembangan terapi modern, meskipun senyawa tersebut memiliki potensi terapeutik yang sangat menjanjikan. Tinjauan naratif ini secara kritis mengevaluasi penggunaan sistem penghantaran obat berskala nano untuk mengatasi keterbatasan biofarmasetika fitokimia hidrofobik serta mengidentifikasi tantangan utama dalam translasi klinis dan produksi skala industri. Tinjauan ini memberikan analisis komprehensif terhadap literatur terbaru mengenai efektivitas modifikasi fisikokimia berbasis nanoteknologi, termasuk nanopartikel lipid padat (Solid Lipid Nanoparticles/SLNs), pembawa lipid terstruktur nano (Nanostructured Lipid Carriers/NLCs), nanosuspensi, misel polimerik, liposom, dan fitosom. Hasil tinjauan menunjukkan bahwa rekayasa nano-pembawa secara signifikan meningkatkan kelarutan, menghindari degradasi metabolik lintas pertama (first-pass metabolism), serta memungkinkan penghantaran obat yang lebih terarah. Secara khusus, nanoformulasi terbukti efektif dalam menembus matriks padat lingkungan mikro tumor (Tumor Microenvironment/TME) pada terapi kanker, melintasi sawar darah otak (Blood-Brain Barrier/BBB) pada penyakit neurodegeneratif, serta melindungi obat dari asam lambung pada kondisi infeksi dan metabolik. Namun, proses transisi menuju komersialisasi masih terhambat oleh masalah stabilitas fisikokimia jangka panjang (misalnya transisi polimorfik lipid) dan tantangan dalam standarisasi bahan baku botani. Permasalahan ini memengaruhi reproduktibilitas produksi skala besar sehingga pada akhirnya memperlambat ketersediaan terapi yang menjanjikan ini bagi pasien yang membutuhkan. Sebagai kesimpulan, meskipun nanoformulasi menawarkan solusi transformatif untuk mengatasi hambatan biologis fitokimia, standarisasi protokol, inovasi sintesis hijau, dan penguatan kolaborasi interdisipliner sangat penting untuk mengatasi hambatan skalabilitas serta mempersiapkan inovasi ini menuju aplikasi klinis.
Unduhan
Rincian Artikel
Artikel ini berlisensiCreative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Referensi
. Cao, J., et al., Solubility improvement of phytochemicals using (natural) deep eutectic solvents and their bioactivity evaluation. Journal of Molecular Liquids, 2020. 318: p. 113997. DOI: https://doi.org/10.1016/j.molliq.2020.113997
. Aljabali, A.A., et al., Phytochemicals in cancer therapy: a structured review of mechanisms, challenges, and progress in personalized treatment. Chemistry & Biodiversity, 2025. 22(8): p. e202402479. DOI: https://doi.org/10.1002/cbdv.202402479
. Hu, Y., et al., Bioaccessibility and bioavailability of phytochemicals: Influencing factors, improvements, and evaluations. Food Hydrocolloids, 2023. 135: p. 108165. DOI: https://doi.org/10.1016/j.foodhyd.2022.108165
. Ansari, M.D., et al., Nanotechnology-enabled delivery of phytoconstituents: Recent developments, applications, and regulatory considerations. Asian Pacific Journal of Tropical Biomedicine, 2026. 16(1): p. 1-23. DOI: https://doi.org/10.4103/apjtb.apjtb_491_25
. Quodbach, J., et al., Novel strategies for the formulation of poorly water-soluble drug substances by different physical modification strategies with a focus on peroral applications. Pharmaceuticals, 2025. 18(8): p. 1089. DOI: https://doi.org/10.3390/ph18081089
. Laffleur, F., G. Millotti, and J. Lagast, An overview of oral bioavailability enhancement through self-emulsifying drug delivery systems. Expert opinion on drug delivery, 2025. 22(5): p. 659-671. DOI: https://doi.org/10.1080/17425247.2025.2479759
. Bhalani, D.V., et al., Bioavailability enhancement techniques for poorly aqueous soluble drugs and therapeutics. Biomedicines, 2022. 10(9): p. 2055. DOI: https://doi.org/10.3390/biomedicines10092055
. Mohite, P., et al., Development and characterization of a self-nano emulsifying drug delivery system (SNEDDS) for Ornidazole to improve solubility and oral bioavailability of BCS class II drugs. Scientific Reports, 2024. 14(1): p. 27724. DOI: https://doi.org/10.1038/s41598-024-73760-7
. Gao, C., et al., Novel drug delivery systems of Chinese medicine for the treatment of inflammatory bowel disease. Chinese medicine, 2019. 14(1): p. 23. DOI: https://doi.org/10.1186/s13020-019-0245-x
. Yadav, S.K. and P. Puranik, Improvements in phytochemical-based drug delivery systems, in Nano-formulation of Dietary Phytochemicals for Cancer Management. 2025, Springer. p. 241-274. DOI: https://doi.org/10.1007/978-981-97-8005-1_9
. Wu, K., et al., Overcoming challenges in small-molecule drug bioavailability: A review of key factors and approaches. International journal of molecular sciences, 2024. 25(23): p. 13121. DOI: https://doi.org/10.3390/ijms252313121
. Blokhina, S.V., et al., Thermodynamic insights to solubility and lipophilicity of new bioactive hybrids triazole with thiazolopyrimidines. Journal of Molecular Liquids, 2021. 324: p. 114662. DOI: https://doi.org/10.1016/j.molliq.2020.114662
. Guan, D., et al., Improving the physicochemical and biopharmaceutical properties of active pharmaceutical ingredients derived from traditional Chinese medicine through cocrystal engineering. Pharmaceutics, 2021. 13(12): p. 2160. DOI: https://doi.org/10.3390/pharmaceutics13122160
. Wu, B., et al., First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics. Journal of pharmaceutical sciences, 2011. 100(9): p. 3655-3681. DOI: https://doi.org/10.1002/jps.22568
. Naritomi, Y., et al., Prediction of hepatic and intestinal glucuronidation using in vitro–in vivo extrapolation. Drug metabolism and pharmacokinetics, 2015. 30(1): p. 21-29. DOI: https://doi.org/10.1016/j.dmpk.2014.10.001
. Ciupei, D., et al., Polyphenols: from classification to therapeutic potential and bioavailability. Foods, 2024. 13(24): p. 4131. DOI: https://doi.org/10.3390/foods13244131
. Thilakarathna, S.H. and H.V. Rupasinghe, Flavonoid bioavailability and attempts for bioavailability enhancement. Nutrients, 2013. 5(9): p. 3367-3387. DOI: https://doi.org/10.3390/nu5093367
. Almeida, A.F., et al., Bioavailability of quercetin in humans with a focus on interindividual variation. Comprehensive reviews in food science and food safety, 2018. 17(3): p. 714-731. DOI: https://doi.org/10.1111/1541-4337.12342
. Talebi, M., et al., Phytosomes: A promising nanocarrier system for enhanced bioavailability and therapeutic efficacy of herbal products. Phytomedicine Plus, 2025. 5(2): p. 100779. DOI: https://doi.org/10.1016/j.phyplu.2025.100779
. Corrales, A., et al., Polymeric micelles for encapsulation of plant-derived bioactives: a decade of advances in antimicrobial, antitumor, and antioxidant applications. Biomaterials Advances, 2026: p. 214713. DOI: https://doi.org/10.1016/j.bioadv.2026.214713
. Fathi, F., et al., Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for the delivery of bioactives sourced from plants: part I–composition and production methods. Expert opinion on drug delivery, 2024. 21(10): p. 1479-1490. DOI: https://doi.org/10.1080/17425247.2024.2410951
. Jacob, S., et al., Solid lipid nanoparticles and nanostructured lipid carriers for anticancer phytochemical delivery: advances, challenges, and future prospects. Pharmaceutics, 2025. 17(8): p. 1079. DOI: https://doi.org/10.3390/pharmaceutics17081079
. Tang, C.-H., H.-L. Chen, and J.-R. Dong, Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) as food-grade nanovehicles for hydrophobic nutraceuticals or bioactives. Applied Sciences, 2023. 13(3): p. 1726. DOI: https://doi.org/10.3390/app13031726
. López, K.L., et al., Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) prepared by microwave and ultrasound-assisted synthesis: promising green strategies for the nanoworld. Pharmaceutics, 2023. 15(5): p. 1333. DOI: https://doi.org/10.3390/pharmaceutics15051333
. Queiroz, M.d.C.V. and L.A. Muehlmann, Characteristics and preparation of solid lipid nanoparticles and nanostructured lipid carriers. Journal of Nanotheranostics, 2024. 5(4): p. 188-211. DOI: https://doi.org/10.3390/jnt5040012
. Aldayel, T.S., et al., Chitosan-coated solid lipid nanoparticles as an efficient avenue for boosted biological activities of Aloe perryi: antioxidant, antibacterial, and anticancer potential. Molecules, 2023. 28(8): p. 3569. DOI: https://doi.org/10.3390/molecules28083569
. Chauhan, I., et al., Nanostructured lipid carriers: A groundbreaking approach for transdermal drug delivery. Advanced pharmaceutical bulletin, 2020. 10(2): p. 150. DOI: https://doi.org/10.34172/apb.2020.021
. Shazwani, S.S., A. Marlina, and M. Misran, Development of nanostructured lipid carrier-loaded flavonoid-enriched Zingiber officinale. ACS omega, 2024. 9(15): p. 17379-17388. DOI: https://doi.org/10.1021/acsomega.4c00091
. Lu, M., et al., Phyto-phospholipid complexes (phytosomes): A novel strategy to improve the bioavailability of active constituents. Asian journal of pharmaceutical sciences, 2019. 14(3): p. 265-274. DOI: https://doi.org/10.1016/j.ajps.2018.05.011
. Aqil, F., et al., Bioavailability of phytochemicals and its enhancement by drug delivery systems. Cancer letters, 2013. 334(1): p. 133-141. DOI: https://doi.org/10.1016/j.canlet.2013.02.032
. Parvin, N., et al., Nano-phytomedicine: harnessing plant-derived phytochemicals in nanocarriers for targeted human health applications. Molecules, 2025. 30(15): p. 3177. DOI: https://doi.org/10.3390/molecules30153177
. Rudzińska, M., et al., Liposomes as carriers of bioactive compounds in human nutrition. Foods, 2024. 13(12): p. 1814. DOI: https://doi.org/10.3390/foods13121814
Camilleri, D., K. Attard, and F. Lia, Formulation and Evaluation of Liposome-Encapsulated Phenolic Compounds from Olive Mill Waste: Insights into Encapsulation Efficiency, Antioxidant, and Cytotoxic Activities. Molecules, 2025. 30(11): p. 2351. DOI: https://doi.org/10.3390/molecules30112351
. Barani, M., et al., Phytosomes as innovative delivery systems for phytochemicals: A comprehensive review of literature. International journal of nanomedicine, 2021: p. 6983-7022. DOI: https://doi.org/10.2147/IJN.S318416
. Toma, L., et al., Bioactive compounds formulated in phytosomes administered as complementary therapy for metabolic disorders. International journal of molecular sciences, 2024. 25(8): p. 4162. DOI: https://doi.org/10.3390/ijms25084162
. Mardiana, L., et al., Phytosome-enhanced secondary metabolites for improved anticancer efficacy: mechanisms and bioavailability review. Drug Design, Development and Therapy, 2025: p. 201-218. DOI: https://doi.org/10.2147/DDDT.S483404
. Mazzotta, E., et al., Formulation of Polymeric Micelles to Increase the Solubility and Photostability of Caffeic Acid. Molecules, 2024. 29(14): p. 3329. DOI: https://doi.org/10.3390/molecules29143329
. Xu, W., P. Ling, and T. Zhang, Polymeric micelles, a promising drug delivery system to enhance bioavailability of poorly water‐soluble drugs. Journal of drug delivery, 2013. 2013(1): p. 340315. DOI: https://doi.org/10.1155/2013/340315
. El-Rafie, H.M., E.A. Hasan, and M.K. Zahran, Enhancement of cytotoxic and antioxidant activities of Digenea simplex chloroform extract using the nanosuspension technique. Bioprocess and Biosystems Engineering, 2023. 46(2): p. 279-296. DOI: https://doi.org/10.1007/s00449-022-02833-6
. Ma, Y., et al., Nanosuspensions technology as a master key for nature products drug delivery and in vivo fate. European Journal of Pharmaceutical Sciences, 2023. 185: p. 106425. DOI: https://doi.org/10.1016/j.ejps.2023.106425
. Zuccari, G. and S. Alfei, Development of phytochemical delivery systems by nano-suspension and nano-emulsion techniques. International Journal of Molecular Sciences, 2023. 24(12): p. 9824. DOI: https://doi.org/10.3390/ijms24129824
Dolatabadi, S., et al., Preparation, characterization and in vivo pharmacokinetic evaluation of curcuminoids-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs). Journal of Drug Delivery Science and Technology, 2021. 62: p. 102352. DOI: https://doi.org/10.1016/j.jddst.2021.102352
. Jäger, R., et al., Comparative absorption of curcumin formulations. Nutrition journal, 2014. 13(1): p. 11. DOI: https://doi.org/10.1186/1475-2891-13-11
. Manjili, H.K., et al., Pharmacokinetics and in vivo delivery of curcumin by copolymeric mPEG-PCL micelles. European Journal of Pharmaceutics and Biopharmaceutics, 2017. 116: p. 17-30. DOI: https://doi.org/10.1016/j.ejpb.2016.10.003
Zhang, B., et al., Physicochemical characterization and oral bioavailability of curcumin–phospholipid complex nanosuspensions prepared based on microfluidic system. Pharmaceutics, 2025. 17(3): p. 395. DOI: https://doi.org/10.3390/pharmaceutics17030395
. Liu, Y., S.A. Hussain, and H. Yue, Protective effects of berberine-loaded chitosan/solid lipid nanoparticles in streptozotocin-induced gestational diabetes mellitus rats. Experimental Biology and Medicine, 2025. 250: p. 10749. DOI: https://doi.org/10.3389/ebm.2025.10749
. Yin, J., et al., Selenium-coated nanostructured lipid carriers used for oral delivery of berberine to accomplish a synergic hypoglycemic effect. International journal of nanomedicine, 2017: p. 8671-8680. DOI: https://doi.org/10.2147/IJN.S144615
. Kutbi, H.I., et al., Optimization of hyaluronate-based liposomes to augment the oral delivery and the bioavailability of berberine. Materials, 2021. 14(19): p. 5759. DOI: https://doi.org/10.3390/ma14195759
. Jia, J., et al., Precise dissolution control and bioavailability evaluation for insoluble drug berberine via a polymeric particle prepared using supercritical CO2. Polymers, 2018. 10(11): p. 1198. DOI: https://doi.org/10.3390/polym10111198
. Alsabeelah, N. and V. Kumar, Quality by design‐based optimization of formulation and process parameters for berberine nanosuspension for enhancing its dissolution rate, bioavailability, and cardioprotective activity. Journal of Food Biochemistry, 2022. 46(10): p. e14361. DOI: https://doi.org/10.1111/jfbc.14361
. Zhang, L., et al., Resveratrol solid lipid nanoparticles to trigger credible inhibition of doxorubicin cardiotoxicity. International journal of nanomedicine, 2019: p. 6061-6071. DOI: https://doi.org/10.2147/IJN.S211130
. Poonia, N., et al., Resveratrol loaded functionalized nanostructured lipid carriers for breast cancer targeting: Systematic development, characterization and pharmacokinetic evaluation. Colloids and Surfaces B: Biointerfaces, 2019. 181: p. 756-766. DOI: https://doi.org/10.1016/j.colsurfb.2019.06.004
. Jagwani, S., et al., Pharmacokinetic and pharmacodynamic evaluation of resveratrol loaded cationic liposomes for targeting hepatocellular carcinoma. ACS Biomaterials Science & Engineering, 2020. 6(9): p. 4969-4984. DOI: https://doi.org/10.1021/acsbiomaterials.0c00429
. Li, T.-P., et al., Physical and pharmacokinetic characterizations of trans-resveratrol (t-Rev) encapsulated with self-assembling lecithin-based mixed polymeric micelles (sa LMPMs). Scientific Reports, 2017. 7(1): p. 10674. DOI: https://doi.org/10.1038/s41598-017-11320-y
. Kuk, D.-H., et al., Development of a resveratrol nanosuspension using the antisolvent precipitation method without solvent removal, based on a quality by design (QbD) approach. Pharmaceutics, 2019. 11(12): p. 688. DOI: https://doi.org/10.3390/pharmaceutics11120688
. Scotti, L. and M.T. Scotti, ADME Properties in Drug Delivery. 2025, MDPI. p. 617. DOI: https://doi.org/10.3390/pharmaceutics17050617
. Tan, S.L.J. and N. Billa, Improved bioavailability of poorly soluble drugs through gastrointestinal muco-adhesion of lipid nanoparticles. Pharmaceutics, 2021. 13(11): p. 1817. DOI: https://doi.org/10.3390/pharmaceutics13111817
Zheng, J., et al., Surface engineering of nanoparticles for precision medicine. Precision Medicine and Engineering, 2025: p. 100037. DOI: https://doi.org/10.1016/j.preme.2025.100037
. Song, Z., et al., Curcumin-loaded PLGA-PEG-PLGA triblock copolymeric micelles: Preparation, pharmacokinetics and distribution in vivo. Journal of colloid and interface science, 2011. 354(1): p. 116-123. DOI: https://doi.org/10.1016/j.jcis.2010.10.024
. Zuo, H.-L., et al., Enzyme activity of natural products on cytochrome P450. Molecules, 2022. 27(2): p. 515. DOI: https://doi.org/10.3390/molecules27020515
. Zhang, R.X., et al., Nanoparticulate drug delivery strategies to address intestinal cytochrome P450 CYP3A4 metabolism towards personalized medicine. Pharmaceutics, 2021. 13(8): p. 1261. DOI: https://doi.org/10.3390/pharmaceutics13081261
. Imam, S.S., et al., Recent advancement in chitosan-based nanoparticles for improved oral bioavailability and bioactivity of phytochemicals: Challenges and perspectives. Polymers, 2021. 13(22): p. 4036. DOI: https://doi.org/10.3390/polym13224036
. Domb, A.J., et al., Safety evaluation of nanotechnology products. Pharmaceutics, 2021. 13(10): p. 1615. DOI: https://doi.org/10.3390/pharmaceutics13101615
. Talluri, S.V., et al., Lipid-based nanocarriers for breast cancer treatment–comprehensive review. Drug delivery, 2016. 23(4): p. 1291-1305. DOI: https://doi.org/10.3109/10717544.2015.1092183
. Chaudhuri, O., et al., Extracellular Matrix Stiffness and Composition Jointly Regulate the Induction of Malignant Phenotypes in Mammary Epithelium. Nat. Mater., 2014. 13(10): p. 970. DOI: https://doi.org/10.1038/nmat4009
. Mahor, A.K., et al., Nanostructured lipid carriers for improved delivery of therapeutics via the oral route. Journal of nanotechnology, 2023. 2023(1): p. 4687959. DOI: https://doi.org/10.1155/2023/4687959
. Makadia, H.K. and S.J. Siegel, Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers, 2011. 3(3): p. 1377-1397. DOI: https://doi.org/10.3390/polym3031377
. Zhang, Y., et al., A surface‐charge study on cellular‐uptake behavior of F3‐peptide‐conjugated iron oxide nanoparticles. Small, 2009. 5(17): p. 1990-1996. DOI: https://doi.org/10.1002/smll.200900520
. Xuan, L., et al., Nanoparticles‐induced potential toxicity on human health: applications, toxicity mechanisms, and evaluation models. MedComm, 2023. 4(4): p. e327. DOI: https://doi.org/10.1002/mco2.327
. Savage, D.T., J.Z. Hilt, and T.D. Dziubla, In vitro methods for assessing nanoparticle toxicity, in Nanotoxicity: Methods and protocols. 2018, Springer. p. 1-29. DOI: https://doi.org/10.1007/978-1-4939-8916-4_1
. Lama, S., O. Merlin-Zhang, and C. Yang, In vitro and in vivo models for evaluating the oral toxicity of nanomedicines. Nanomaterials, 2020. 10(11): p. 2177. DOI: https://doi.org/10.3390/nano10112177
Kumar, R., et al., Nanotoxicity unveiled: Evaluating exposure risks and assessing the impact of nanoparticles on human health. Journal of Trace Elements and Minerals, 2025. 13: p. 100252. DOI: https://doi.org/10.1016/j.jtemin.2025.100252
. Michael, P.L., et al., Comprehensive evaluation of the toxicity and biosafety of plasma polymerized nanoparticles. Nanomaterials, 2021. 11(5): p. 1176. DOI: https://doi.org/10.3390/nano11051176
. Shao, X., et al., Tumor microenvironment targeted nano-drug delivery systems for multidrug resistant tumor therapy. Theranostics, 2025. 15(5): p. 1689. DOI: https://doi.org/10.7150/thno.103636
. Shawky, S., et al., Quercetin loaded cationic solid lipid nanoparticles in a mucoadhesive in situ gel—a novel intravesical therapy tackling bladder cancer. Pharmaceutics, 2022. 14(11): p. 2527. DOI: https://doi.org/10.3390/pharmaceutics14112527
. Esfandiarpour-Boroujeni, S., et al., Fabrication and study of curcumin loaded nanoparticles based on folate-chitosan for breast cancer therapy application. Carbohydrate polymers, 2017. 168: p. 14-21. DOI: https://doi.org/10.1016/j.carbpol.2017.03.031
. Li, S., et al., Enhancing betulinic acid dissolution rate and improving antitumor activity via nanosuspension constructed by anti-solvent technique. Drug Design, Development and Therapy, 2020: p. 243-256. DOI: https://doi.org/10.2147/DDDT.S233851
. Kumar, V., S. Sharma, and A. Singh, Nanoparticles: a new frontier in neurodegenerative disease therapy. Frontiers in Medical Technology, 2025. 7: p. 1654003. DOI: https://doi.org/10.3389/fmedt.2025.1654003
. Razavi, Z.S., et al., Advancing neurological disorders therapies: Organic nanoparticles as a key to blood-brain barrier penetration. International Journal of Pharmaceutics, 2025. 670: p. 125186. DOI: https://doi.org/10.1016/j.ijpharm.2025.125186
. Ullah, F., et al., Evaluation of phytosomal curcumin as an anti-inflammatory agent for chronic glial activation in the GFAP-IL6 mouse model. Frontiers in neuroscience, 2020. 14: p. 170. DOI: https://doi.org/10.3389/fnins.2020.00170
. Noor, N.A., et al., Effect of curcumin nanoparticles on streptozotocin-induced male Wistar rat model of Alzheimer’s disease. Metabolic brain disease, 2022. 37(2): p. 343-357. DOI: https://doi.org/10.1007/s11011-021-00897-z
. Meng, F., et al., A novel LDL-mimic nanocarrier for the targeted delivery of curcumin into the brain to treat Alzheimer's disease. Colloids and Surfaces B: Biointerfaces, 2015. 134: p. 88-97. DOI: https://doi.org/10.1016/j.colsurfb.2015.06.025
. Pinheiro, R., et al., Quercetin lipid nanoparticles functionalized with transferrin for Alzheimer's disease. European Journal of Pharmaceutical Sciences, 2020. 148: p. 105314. DOI: https://doi.org/10.1016/j.ejps.2020.105314
. Taghipour, Y.D., et al., Nanoformulations of natural products for management of metabolic syndrome. International journal of nanomedicine, 2019: p. 5303-5321. DOI: https://doi.org/10.2147/IJN.S213831
. Xue, M., et al., Characterization, pharmacokinetics, and hypoglycemic effect of berberine loaded solid lipid nanoparticles. International journal of nanomedicine, 2013: p. 4677-4687. DOI: https://doi.org/10.2147/IJN.S51262
. Maity, S., et al., Alginate coated chitosan core-shell nanoparticles for efficient oral delivery of naringenin in diabetic animals—An in vitro and in vivo approach. Carbohydrate Polymers, 2017. 170: p. 124-132. DOI: https://doi.org/10.1016/j.carbpol.2017.04.066
. Yusuf, H., et al., Curcumin micelles entrapped in eudragit S-100 matrix: a synergistic strategy for enhanced oral delivery. Future Science OA, 2021. 7(4): p. FSO677. DOI: https://doi.org/10.2144/fsoa-2020-0131
. Vanti, G., et al., Nanostructured lipid carriers can enhance oral absorption of khellin, a natural pleiotropic molecule. Molecules, 2021. 26(24): p. 7657. DOI: https://doi.org/10.3390/molecules26247657
. Ang, S.-S., Y.Y. Thoo, and L.F. Siow, Encapsulation of hydrophobic apigenin into small unilamellar liposomes coated with chitosan through ethanol injection and spray drying. Food and bioprocess technology, 2024. 17(2): p. 424-439. DOI: https://doi.org/10.1007/s11947-023-03140-y
. Deng, J., et al., Berberine-loaded nanostructured lipid carriers enhance the treatment of ulcerative colitis. International journal of nanomedicine, 2020: p. 3937-3951. DOI: https://doi.org/10.2147/IJN.S247406
. Singh, R.P., H. Gangadharappa, and K. Mruthunjaya, Phytosome complexed with chitosan for gingerol delivery in the treatment of respiratory infection: In vitro and in vivo evaluation. European Journal of Pharmaceutical Sciences, 2018. 122: p. 214-229. DOI: https://doi.org/10.1016/j.ejps.2018.06.028
. Gupta, A., et al., Formulation and characterization of curcumin loaded polymeric micelles produced via continuous processing. International journal of pharmaceutics, 2020. 583: p. 119340. DOI: https://doi.org/10.1016/j.ijpharm.2020.119340
. Talarico, L., et al., Solid lipid nanoparticles produced via a coacervation method as promising carriers for controlled release of quercetin. Molecules, 2021. 26(9): p. 2694. DOI: https://doi.org/10.3390/molecules26092694
. de Jesús Valle, M.J., et al., Resveratrol liposomes in buccal formulations, an approach to overcome drawbacks limiting the application of the phytoactive molecule for chemoprevention and treatment of oral cancer. Journal of Drug Delivery Science and Technology, 2024. 98: p. 105910. DOI: https://doi.org/10.1016/j.jddst.2024.105910
. Ghosh, S., et al., Nanomaterials for delivery of medicinal plant extracts and phytochemicals: Potential applications and future perspectives. Plant Nano Biology, 2025. 12: p. 100161. DOI: https://doi.org/10.1016/j.plana.2025.100161
. Kawish, S.M., et al., Nanoparticle‐based drug delivery platform for simultaneous administration of phytochemicals and chemotherapeutics: emerging trends in cancer management. Particle & Particle Systems Characterization, 2024. 41(12): p. 2400049. DOI: https://doi.org/10.1002/ppsc.202400049
. Plyduang, T., C. Monton, and J. Suksaeree, Sustainable Green Extraction Approaches for Herbal Phytochemicals Supporting Environmentally Friendly and Climate Responsive Product Development. Sustainable Chemistry for Climate Action, 2026: p. 100184. DOI: https://doi.org/10.1016/j.scca.2026.100184
. Patnala, S. and I. Kanfer, Quality control, extraction methods, and standardization: Interface between traditional use and scientific investigation, in Herbal Medicine in Andrology. 2021, Elsevier. p. 175-187. DOI: https://doi.org/10.1016/B978-0-12-815565-3.00006-0
. Joseph, T.M., et al., Nanoparticles: taking a unique position in medicine. Nanomaterials, 2023. 13(3): p. 574. DOI: https://doi.org/10.3390/nano13030574
Priani, S.E., et al., Quality by design and in silico approach in SNEDDS development: a comprehensive formulation framework. Pharmaceutics, 2025. 17(6): p. 701. DOI: https://doi.org/10.3390/pharmaceutics17060701
. Tarahi, M., et al., Plant-based delivery systems for bioactive compounds: Mechanisms of release and functional food applications. Advances in Colloid and Interface Science, 2026: p. 103787. DOI: https://doi.org/10.1016/j.cis.2026.103787
. Yenduri, G., et al., Impact of critical process parameters and critical material attributes on the critical quality attributes of liposomal formulations prepared using continuous processing. International journal of pharmaceutics, 2022. 619: p. 121700. DOI: https://doi.org/10.1016/j.ijpharm.2022.121700
. Alshaer, W., et al., Quality by design approach in liposomal formulations: Robust product development. Molecules, 2022. 28(1): p. 10. DOI: https://doi.org/10.3390/molecules28010010
Mendes, M., et al. Designing Ultra-Small Nanostructured Lipid Carriers: Critical Process Parameters. in Proceedings. 2020. MDPI. DOI: https://doi.org/10.3390/IECP2020-08691
Beraldo-Araújo, V.L., et al., Levofloxacin in nanostructured lipid carriers: Preformulation and critical process parameters for a highly incorporated formulation. International journal of pharmaceutics, 2022. 626: p. 122193. DOI: https://doi.org/10.1016/j.ijpharm.2022.122193
. Hidayat, A.F., et al., A Review on QbD-Driven Optimization of Lipid Nanoparticles for Oral Drug Delivery: From Framework to Formulation. International Journal of Nanomedicine, 2025: p. 8611-8651. DOI: https://doi.org/10.2147/IJN.S534137
. Cho, S., et al., From conventional to next-generation strategies: recent advances in polymeric micelle preparation for drug delivery. Pharmaceutics, 2025. 17(10): p. 1360. DOI: https://doi.org/10.3390/pharmaceutics17101360
. Scioli Montoto, S., G. Muraca, and M.E. Ruiz, Solid lipid nanoparticles for drug delivery: pharmacological and biopharmaceutical aspects. Frontiers in molecular biosciences, 2020. 7: p. 587997. DOI: https://doi.org/10.3389/fmolb.2020.587997
. Franzé, S., et al., Lyophilization of liposomal formulations: still necessary, still challenging. Pharmaceutics, 2018. 10(3): p. 139. DOI: https://doi.org/10.3390/pharmaceutics10030139
. Yu, J.Y., et al., Post-processing techniques for the improvement of liposome stability. Pharmaceutics, 2021. 13(7): p. 1023. DOI: https://doi.org/10.3390/pharmaceutics13071023
. Chiu, M.H. and E.J. Prenner, Differential scanning calorimetry: An invaluable tool for a detailed thermodynamic characterization of macromolecules and their interactions. Journal of Pharmacy and Bioallied Sciences, 2011. 3(1): p. 39-59. DOI: https://doi.org/10.4103/0975-7406.76463
Klein, I. and D. Steiner, Development and application of a novel tracer system for the evaluation of temperature exposure of lipid nanoparticles in spray drying and dual centrifugation. European Journal of Pharmaceutics and Biopharmaceutics, 2025: p. 114889. DOI: https://doi.org/10.1016/j.ejpb.2025.114889
. Dwiputra, R.R., J.R. Saputri, and M.R. Utami, Applications and Future Potential of X-ray Diffraction in Pharmaceutical Polymorphism: A Literature Review. Indonesian Journal of Chemistry and Environment, 2024. 7(2): p. 93-103. DOI: https://doi.org/10.21831/ijoce.v7i2.79071
. Barnes, M., et al., Fourier transform infrared spectroscopy as a non-destructive method for analysing herbarium specimens. Biology Letters, 2023. 19(3). DOI: https://doi.org/10.1098/rsbl.2022.0546
. Yu, D., et al., Nanotechnology-Enabled Delivery of Phytochemicals: From Formulation Strategies to Therapeutic Translation. Journal of Phytomedicine, 2026. 1(1): p. 4. DOI: https://doi.org/10.3390/jphytomed1010004
. Peters, S.A., et al., Predicting drug extraction in the human gut wall: assessing contributions from drug metabolizing enzymes and transporter proteins using preclinical models. Clinical pharmacokinetics, 2016. 55(6): p. 673-696. DOI: https://doi.org/10.1007/s40262-015-0351-6
. Patel, J., et al., Natural lipid-based nanoformulations for enhancing hepatoprotective activity: mechanisms, efficacy, and clinical translation. Health Nanotechnology, 2025. 1(1): p. 11. DOI: https://doi.org/10.1186/s44301-025-00010-8
. Moghimi, S.M. and D. Simberg, Translational gaps in animal models of human infusion reactions to nanomedicines. 2018, Taylor & Francis. p. 973-975. DOI: https://doi.org/10.2217/nnm-2018-0064
. Hou, N., X. Du, and S. Wu, Advances in pig models of human diseases. Animal Models and Experimental Medicine, 2022. 5(2): p. 141-152. DOI: https://doi.org/10.1002/ame2.12223
. Hodkovicova, N., et al., The use of silver nanoparticles in pigs–An invited review. Veterinární medicína, 2025. 70(3): p. 77. DOI: https://doi.org/10.17221/101/2024-VETMED